Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension

T Quinaglia1, L C Martins, V N Figueiredo

  • 1Department of Internal Medicine, Cardiovascular Pharmacology Laboratory, Faculty of Medical Sciences and Clinic Hospital, State University of Campinas, São Paulo, Brazil.

Insights

Patients with uncontrolled resistant hypertension (RHTN) show reduced nocturnal blood pressure dipping and impaired endothelial function compared to controlled RHTN patients, suggesting distinct cardiovascular risk profiles.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Hypertension Research

Background:

  • Resistant hypertension (RHTN) encompasses patients with uncontrolled blood pressure (BP) on multiple medications (uncontrolled RHTN - UCRH) and those controlled on four or more drugs (controlled RHTN - CRH).
  • The differences in endothelial function and circadian BP patterns between UCRH and CRH patient groups remain largely unknown.
  • Understanding these distinctions is crucial for stratifying cardiovascular risk within RHTN populations.

Purpose of the Study:

  • To investigate and compare circadian BP patterns and vascular endothelial function in patients with UCRH and CRH.
  • To identify potential differences in endothelial-dependent and independent vasodilation between these RHTN subgroups.
  • To explore whether these physiological differences correlate with varying cardiovascular risk.

Main Methods:

  • Ambulatory BP monitoring was used to assess circadian BP patterns, including nocturnal dipping of systolic BP (SBP) and diastolic BP (DBP).
  • Vascular function was evaluated by measuring brachial artery responses to endothelial-dependent (flow-mediated dilation - FMD) and endothelial-independent (nitroglycerin-mediated) stimuli.
  • Biochemical testing was performed on 40 CRH patients, 26 UCRH patients, and 25 normotensive controls.

Main Results:

  • The nighttime BP drop was significantly less pronounced in UCRH patients compared to CRH patients (SBP: 1.9% vs. 4.9%; DBP: 7.5% vs. 10.9%).
  • Endothelial-dependent flow-mediated dilation (FMD) was significantly impaired in UCRH patients (5.9%) compared to CRH patients (7.1%).
  • Normotensive controls exhibited better FMD than both RHTN groups, and RHTN patients generally showed impaired vascular function compared to controls.

Conclusions:

  • Uncontrolled RHTN patients exhibit diminished nocturnal blood pressure dipping and more severe endothelial dysfunction compared to controlled RHTN patients.
  • These findings highlight significant physiological differences between UCRH and CRH subgroups.
  • Identifying these distinct RHTN subgroups may aid in better risk stratification and personalized management strategies for patients with resistant hypertension.

Related Concept Videos

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...